Pharmabiz22h
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance: Vancouver, BC Saturday, February 1, 2025, ...
Pharmabiz22h
Union budget 2025 defeats the objective of Make in India programme: KDPMA
Union budget 2025 defeats the objective of Make in India programme: KDPMA: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 17:20 Hrs [IST] The Karnataka Drugs and Pharm ...
Pharmabiz1d
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...
Pharmabiz23h
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria: Our Bureau, Bengaluru Saturday, February 1, 2025, 16:45 Hrs [IST] India pharma ...
Pharmabiz23h
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb: Melbourne, Australia Saturday, February 1, 2025, 1 ...
Pharmabiz23h
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare: Our Bureau, New Delhi Saturday, February 1, 2025, 17:05 Hrs [IST] The Union Budget 2025 has prop ...
Pharmabiz1d
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...
Pharmabiz1d
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...
Pharmabiz1d
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...
Pharmabiz1d
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
Pharmabiz1d
Medical devices industry disappointed over Union Budget 2025
With the Union Budget 2025 skipped mentioning medical devices sector directly or addressing the industry demands including custom duty structure, the industry associations said that they are ...
Pharmabiz1d
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...